Publication | Open Access

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Relapsing-remitting Multiple SclerosisMedicineClinical NeurologyClinical TrialsNeurological ProgressNeurologyOral FumarateMultiple SclerosisNeuroimmunology